Book a Meeting

Anti-Transmembrane protein 30A Antibody, Non-Fucosylated (CAT#: BioBet-1364ZP) Datasheet

Target
Transmembrane protein 30A
Isotype
IgG
Description
Anti-Transmembrane protein 30A Antibody, Non-Fucosylated (BioBet-1364ZP) is a humanized monoclonal IgG antibody against Transmembrane protein 30A. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Neurological Diseases
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Transmembrane protein 30A antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
TMEM30A
Full Name
transmembrane protein 30A
Alternative Names
TMEM30A; transmembrane protein 30A; CDC50A; C6orf67; cell cycle control protein 50A; P4-ATPase flippase complex beta subunit TMEM30A
Gene ID
55754
Cellular Localization
Golgi apparatus, Plasma membrane
Involvement in Disease
Diseases associated with TMEM30A include Cholestasis, Benign Recurrent Intrahepatic, 1 and Progressive Familial Intrahepatic Cholestasis.
Related Pathways
Its related pathways are Innate Immune System.
Post-translational modifications
1.N-glycosylated. Contains high mannose-type oligosaccharides (By similarity) 2.Modification sites at PhosphoSitePlus 3.Glycosylation at Asn180, Asn190, Thr285, and Asn294 4.Ubiquitination at Lys8, Lys24, Lys210, and Lys21
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
BioBet-1364ZP
Host
Humanized
Species Reactivity
Human
Description
ADCC-Enhanced anti-Transmembrane protein 30A (FC5) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform.
Antibody Indication
Neurological Diseases

Neurological Diseases

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.